Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Post by WarrantOfficeron Dec 22, 2023 5:17pm
145 Views
Post# 35798565

Independent Review Committee Required

Independent Review Committee RequiredI put forth a notion that shareholders begin to band together to extract the true forward traction of this company. Management will share Rain Cage fullerene information, but will not share what work directors and the Scientific Advisory Board have completed or in the progress of?

Personally, I want to know what avenues of financing have been attempted, the number of loan rejections, specific reasons why it has taken almost 3 years to get 5 products thru the proper testing procedures, why there is not more frequent shareholder updates and where is the tons of Voyageur barium sulphate pictured in Resource World Magazine Sept 2019 publication?  

This years minimal accomplishments: closed a PP, issued shares for debt, completed a comparative study for Smooth X, filed financial statements on multiple occasions, announced options and DSU's on multiple occasions, published a white paper on SmoothX, completed the formulation of HDXBa and partnered with Rain Cage. 

How long will Rain Cage stay partnered with Voyaguer whilst Voyaguer forward traction seems to move forward at a snails pace. I can honestly state a snails pace as I gander upon this years accomplishments. 

IMO it seems management deems shareholders do not have the right to be cognizant of pertinent company issues. It is time shareholders band together. We need about a combined 20 million shares total to inform management of our demands. It seems they deem our need to be well informed of less importance than the DSU's issued to directors. 

I will tip my hat to management if they can prove me wrong, but I am simply going by all the information I can find. 


<< Previous
Bullboard Posts
Next >>